Anaptysbio (ANAB) Free Cash Flow (2016 - 2026)
Anaptysbio (ANAB) reported Free Cash Flow of -$25.9 million for Q1 2026, down 141.6% on a YoY basis from $62.3 million in Q1 2025, and down 126.47% quarter-over-quarter from $98.0 million in Q4 2025.
Anaptysbio (ANAB) Free Cash Flow (2016 - 2026) Analysis & Trends
Anaptysbio has reported Free Cash Flow for 11 years, with the latest figure at -$25.9 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 141.6% year-over-year to -$25.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 104.04% YoY), and the FY2025 full-year result was $19.6 million, up 114.45% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$25.9 million, down from $98.0 million in the prior quarter.
- The five-year high for Free Cash Flow was $98.0 million in Q4 2025, with the low at -$66.9 million in Q4 2024.
- Historically, Free Cash Flow has averaged -$19.8 million across 5 years, with a median of -$24.7 million in 2023.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 377.97% — and 2025, when it soared 246.4%.
- Anaptysbio's Free Cash Flow stood at -$10.8 million in 2022, then plunged by 222.61% to -$34.9 million in 2023, then sank by 91.92% to -$66.9 million in 2024, then soared by 246.4% to $98.0 million in 2025, then sank by 126.47% to -$25.9 million in 2026.
- The last three Free Cash Flow figures came in at -$25.9 million (Q1 2026), $98.0 million (Q4 2025), and -$27.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | -25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.94 Mn |
| Mar 31, 2026 | -25.94 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Sep 30, 2025 | -27.37 Mn |
| Sep 30, 2025 | -27.37 Mn |
| Jun 30, 2025 | -40.28 Mn |
| Jun 30, 2025 | -40.28 Mn |
| Mar 31, 2025 | -10.74 Mn |
| Mar 31, 2025 | -10.74 Mn |
| Dec 31, 2024 | -66.94 Mn |
| Dec 31, 2024 | -66.94 Mn |
| Sep 30, 2024 | -10.13 Mn |
| Sep 30, 2024 | -10.13 Mn |
| Jun 30, 2024 | -21.36 Mn |
| Jun 30, 2024 | -21.36 Mn |
| Mar 31, 2024 | -37.28 Mn |
| Mar 31, 2024 | -37.28 Mn |
| Dec 31, 2023 | -34.88 Mn |
| Dec 31, 2023 | -34.88 Mn |